跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
恩瑞舒 - NMPA Drug Approval Details
Approvals
/
NMPA
/
Abatacept Injection
Approved
生物制品
Abatacept Injection
Bristol-Myers Squibb Company
🇨🇳 National Medical Products Administration
Approval Date
Jan 8, 2020
Approval ID
7uciuWB4Qn7
Company
Bristol-Myers Squibb Company
Type
生物制品
Approval Details
Approval Id
7uciuWB4Qn7
Approval Number
S20200001
Generic Name
阿巴西普注射液
Generic Name En
Abatacept Injection
Trade Name
恩瑞舒
Drug Type
生物制品
Dosage Form
注射剂
Strength
125mg(0.95mL)/支(预充式注射器)
Reg Date
2020-01-08
Expired Date
2025-01-07
Company Name
Bristol-Myers Squibb Company
Company Address
PO Box 4000, Princeton, NJ 08543, USA
Production Company Name
bristol-myers squibb holdings pharma, ltd. liability company
Production Company Address
Road 686 Km 2.3, Bo. Tierras Nuevas, Manati, PUERTO RICO, 00674, USA
Company Detail Path
/organization/bristol-myers-squibb-company
Approved
Quick Info
Agency
NMPA
Country
🇨🇳
Approval Date
Jan 8, 2020
Approval ID
7uciuWB4Qn7
Type
生物制品
Back to NMPA Approvals